您的位置: 首页 > 农业专利 > 详情页

Amyloid-beta(1-42)-Oligomere, Derivate davon und Antikörper dafür, Verfahren zu deren Herstellung und deren Verwendung
专利权人:
AbbVie Deutschland GmbH & Co KG
发明人:
Hillen, Heinz,Striebinger, Andreas,Krantz, Carsten,Moeller, Achim,Mueller, Reinhold
申请号:
EP10179281.0
公开号:
EP2336161B1
申请日:
2004.02.02
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Oligomers (A) of the amyloid beta (1-42) peptide (I) that have apparent molecular weights, in sodium deodecylsulfate gel electrophoresis, of about 15 (A1), 20 (A2), 38 (A3) and 48 (A4) kD, and their derivatives, are new. Independent claims are also included for the following: (1) composition (B) comprising a mixture of A1 and A2 or of A3 and A4 (2) preparing (A) by treating monomeric (I), or its derivatives, with a detergent (3) characterizing a substance, or mixture, by contacting with (A), their derivatives, or (B) and determining any binding to (A) or derivatives (4) substances, or parts of substance mixtures, identified by method (3) as (A)-binding ligands (5) preparing antibodies (Ab) by immunizing a host with (A), or its derivative, or (B) and (6) Ab prepared by method (5). ACTIVITY : Nootropic Neuroprotective. No details of tests for these activities are given. MECHANISM OF ACTION : (A) reduce survival of neuronal cells, especially neuroblastoma, by inducing apoptosis, and in vivo they modulate the firing rate of neurons.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充